NCT00616681View on ClinicalTrials.gov

Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
SeizuresEpilepsy
Interventions
DRUG

Oxcarbazepine

Trial Locations (1)

H4R 2N6

MDS Pharma Services, Montreal

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00616681 - Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter